Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Reflex Earache in Head and Neck Cancer
NCT02924675Phase 2Terminated
- Sponsor
- CHU de Lille
- Start
- Jun 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Pregabalin group with Placebo group (2 arms). Primary endpoint: Decreased intensity of pain in referred otalgia at 3 weeks. Started Jun 2015; status: terminated.
02
Drugs
pregabalin
Beyond the preview
Go deeper on NCT02924675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02924675.